Abstract
Helicobacter pylori (HP) occurs in 50% of people worldwide with higher rates reported in the bariatric population. HP has been associated with adverse outcomes following bariatric surgery; however, its true impact has not yet been defined. We aimed to systematically review the effect of HP on bariatric surgery outcomes. A comprehensive literature review was conducted yielding seven studies with 255,435 patients. Meta-analysis found comparable rates of bleeding, leak, hospital length of stay, and weight loss between HP-positive and HP-negative patients. HP was, however, found to be the largest independent predictor of marginal ulceration in those undergoing RYGB, with a tenfold increase versus HP-negative patients. Overall, HP is associated with increased marginal ulceration rates, but has little impact on other bariatric surgery outcomes.
Similar content being viewed by others
References
Rawlins L. Effect of Helicobacter pylori on marginal ulcer and stomal stenosis after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9(5):760–4. https://doi.org/10.1016/j.soard.2012.06.012.
Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000;22(2):283–97. https://doi.org/10.1093/oxfordjournals.epirev.a018040.
Yang CS. The Influence of Helicobacter pylori infection on the development of gastric ulcer in symptomatic patients after bariatric surgery. Obes Surg. 16:735–9.
Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288(14):1723–7. https://doi.org/10.1001/jama.288.14.1723.
Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA. 2002;288(22):2793–6. https://doi.org/10.1001/jama.288.22.2793.
Arslan E, Atilgan H, Yavaşoğlu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med. 2009;20(7):695–7. https://doi.org/10.1016/j.ejim.2009.07.013.
Erim T, Cruz-Correa MR, Szomstein S, et al. Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: a preliminary study. World J Surg. 2008;32(9):2021–5. https://doi.org/10.1007/s00268-008-9608-7.
Carabotti M et al. Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery. World J Gastroenterol. 2014;20(3):647–53.
Capella JF, Capella RF. Staple disruption and marginal ulceration in gastric bypass procedures for weight reduction. Obes Surg. 1996;6(1):44–9. https://doi.org/10.1381/096089296765557259.
Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4. https://doi.org/10.1007/s00464-007-9285-x.
Csendes A, Burgos AM, Altuve J, et al. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg. 2009 Feb;19(2):135–8. https://doi.org/10.1007/s11695-008-9588-6.
Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19(2):200–21. https://doi.org/10.1007/s00464-004-9194-1.
SAGES Guidelines Committee. SAGES guidelines for clinical application of laparoscopic bariatric surgery. Surg Endosc. 2008;22(10):2281–300. https://doi.org/10.1007/s00464-008-9913-0.
Zanotti D, Elkalawwy M, Hashemi M, et al. Current status of preoperative oesophago-gastro-duodenoscopy (OGD) in bariatric NHS units—a BOMSS survey. Paper presented at BOMSS6th Annual Scientific Meeting, January 22-23, 2015, Newcastle, UK.
Kelly JJ. The presence of Helicobacter pylori is not associated with long-term anastomotic complications in gastric bypass patients. Surg Endosc. 2015;29(10):2885–90. https://doi.org/10.1007/s00464-014-4022-8.
Papasavas PK. Prevalence of Helicobacter pylori infection and value of preoperative testing and treatment in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4(3):383–8. https://doi.org/10.1016/j.soard.2007.08.014.
Rossetti G. Does helicobacter pylori infection have influence on outcome of laparoscopic sleeve gastrectomy for morbid obesity? Int J Surg. 2014;12:68–S71.
Slim K, Nini E, Forestier D, et al. Methodological Index for non-randomized studies (MINORS): development and validation of a new instrument. J Surg. 2003;73:712–6.
Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.
Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. https://doi.org/10.1136/bmj.327.7414.557.
Shanti H, Almajali N, Al-Shamaileh T, et al. Helicobacter pylori does not affect postoperative outcomes after sleeve gastrectomy. Obes Surg. 2017;27(5):1298–301. https://doi.org/10.1007/s11695-016-2470-z.
Brownlee AR, Bromber E, Roslin MS. Outcomes in patients with Helicobacter pylori undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2015;25(12):2276–9. https://doi.org/10.1007/s11695-015-1687-6.
Gomberawalla A, Lutfi R. Early outcomes of Helicobacter pylori and its treatment after laparoscopic sleeve gastrectomy. Bariatr Surg Pract Patient Care. 2015;10(1):12–4. https://doi.org/10.1089/bari.2014.0011.
Ramaswami A et al. Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery. Arch Surg. 2004;139(10):1094–6. https://doi.org/10.1001/archsurg.139.10.1094.
Schulman A, Abougergi M, Thompson CH. Pylori as a predictor of marginal ulceration: a nationwide analysis. Obesity. 2017;25(3):522–6. https://doi.org/10.1002/oby.21759.
Wang H et al. The influence of Helicobacter pylori infection and corpus gastritis on the postoperative outcomes of laparoscopic vertical banded gastroplasty. Obes Surg. 2006;16(3):297–307. https://doi.org/10.1381/096089206776116417.
Buchwald H, Cowan G, Pories W. Surgical management of obesity: Philadelphia, WB Saunders; 2007. p. 297–303.
Patel SK, Pratap CB, Jain AK, et al. Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol. 2014;20(36):12847–59. https://doi.org/10.3748/wjg.v20.i36.12847.
Wang YK, Kuo FC, Liu CJ, et al. Diagnosis of Helicobacter pylori infection: current options and developments. World J Gastroeneterol. 2015;21(40):11221–35. https://doi.org/10.3748/wjg.v21.i40.11221.
Testerman TL, Morris J. Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol. 2014;20(36):12781–808. https://doi.org/10.3748/wjg.v20.i36.12781.
Bockerstett KA, Dipaolo RJ. Regulation of gastric carcinogenesis by inflammatory cytokines. Cell Mol Gastroenterol Hepatol. 2017;4(1):47–53. https://doi.org/10.1016/j.jcmgh.2017.03.005.
Tegtmeyer N, Nedermann M, Asche CI, et al. Subversion of host kinases: a key network in cellular signaling hijacked by Helicobacter pylori CagA. Mel Microbiol. 2017;00:00–0.
Azagury DE, Dayeh A, Greenwalt IT, et al. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment and outcomes. Endoscopy. 2011;43(11):950–4. https://doi.org/10.1055/s-0030-1256951.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval and Consent
This article does not contain any studies with human participants or animals performed by any of the authors.
For this type of study, formal consent is not required. Informed consent does not apply.
Conflict of Interest Statement
Authors 1, 2, 3, 4, 5, and 6—none to declare.
Author 7 is a consultant and has received educational grants from Ethicon and Covidien, educational grants from Stryker, and teaching honoraria from Cook Surgery and Bard Davol.
Author 8 is a consultant for Gore Medical and Ethicon.
Rights and permissions
About this article
Cite this article
Mocanu, V., Dang, J.T., Switzer, N. et al. The Effect of Helicobacter pylori on Postoperative Outcomes in Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis. OBES SURG 28, 567–573 (2018). https://doi.org/10.1007/s11695-017-3024-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-017-3024-8